Stay updated on Soticlestat in Dup 15q and CDKL5 Disorders Clinical Trial
Sign up to get notified when there's something new on the Soticlestat in Dup 15q and CDKL5 Disorders Clinical Trial page.

Latest updates to the Soticlestat in Dup 15q and CDKL5 Disorders Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page footer now shows Revision: v3.3.4 (replacing v3.3.3). This is a metadata/version label update and does not modify study information, eligibility criteria, locations, or other user-facing content.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check30 days agoChange DetectedLocations are reorganized into a single 'Locations' section listing sites by state (CA, CO, GA, MA, MN, NY), replacing separate 'X Locations' headings. This changes how potential participants locate and contact trial sites.SummaryDifference0.7%

- Check58 days agoChange DetectedPublications description updated to state that entries are automatically filled from PubMed, and the revision label shows v3.3.2 (replacing the previous v3.2.0).SummaryDifference0.1%

- Check65 days agoChange DetectedThe government funding lapse notice previously displayed on the page has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check80 days agoChange DetectedNo significant changes detected; only minor visual/layout refinements observed with no updates to study details, eligibility, enrollment, locations, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check108 days agoChange DetectedUpdated the page to v3.2.0 with a new resource (15q11q13 microduplication syndrome) and a government-operating-status notice; previous version v3.1.0 is now superseded.SummaryDifference3%

Stay in the know with updates to Soticlestat in Dup 15q and CDKL5 Disorders Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Soticlestat in Dup 15q and CDKL5 Disorders Clinical Trial page.